Abstract
This article reviews the current evidence on the cost–effectiveness of psychotherapy for personality disorders (PDs). Although the evidence is still scarce, several well-designed cost–effectiveness studies provide insight into the question – how cost effective is it to reimburse therapies for PDs? This article further argues that the implementation costs and effects should be an integral part of cost–effectiveness analyses to enhance the dissemination of treatment recommendations. Moreover, cost–effectiveness analyses are important in working towards a more patient-centered approach in psychotherapy research that could potentially help accelerate the implementation and adoption of cost-effective care for PDs.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.